Average Insider

Where insiders trade, we follow

Dyne Therapeutics, Inc. ($DYN)
Accession: 0001577014-26-000008
May 6, 2026
๐Ÿ“ˆ Chart on TradingView๐Ÿ’ฐ Financials on Finviz
52W Low$8.06
Current$18.8463.6% above low, 36.4% below high
52W High$25.00

Filing Information

Accession Number0001577014-26-000008
Form Type4
Filing DateMay 6, 2026
DocumentView SEC Filing
Transactions
12
Total Shares
106,723
Total Value
$1,936,341.42

Transactions

NameTitleSecurityDerivativeTransaction DateTypeSharesPriceTotal CostShares AfterDirect/IndirectNature of OwnershipActions
Rhodes Jason P
Director
Common Stock
โ€”May 4, 2026Sale3,136$18.00$56,448.001,574,270IndirectSee footnoteView Details
Rhodes Jason P
Director
Common Stock
โ€”May 4, 2026Sale6,241$18.00$112,338.004,933,196IndirectSee footnoteView Details
Rhodes Jason P
Director
Common Stock
โ€”May 4, 2026Sale61$18.00$1,098.008,450IndirectSee footnoteView Details
Rhodes Jason P
Director
Common Stock
โ€”May 4, 2026Sale2,466$18.00$44,388.001,156,457IndirectSee footnoteView Details
Rhodes Jason P
Director
Common Stock
โ€”May 5, 2026Sale3,056$18.03$55,099.681,571,214IndirectSee footnoteView Details
Rhodes Jason P
Director
Common Stock
โ€”May 5, 2026Sale6,081$18.03$109,640.434,927,115IndirectSee footnoteView Details
Rhodes Jason P
Director
Common Stock
โ€”May 5, 2026Sale60$18.03$1,081.808,390IndirectSee footnoteView Details
Rhodes Jason P
Director
Common Stock
โ€”May 5, 2026Sale2,403$18.03$43,326.091,154,054IndirectSee footnoteView Details
Rhodes Jason P
Director
Common Stock
โ€”May 6, 2026Sale21,926$18.18$398,614.681,549,288IndirectSee footnoteView Details
Rhodes Jason P
Director
Common Stock
โ€”May 6, 2026Sale43,621$18.18$793,029.784,883,494IndirectSee footnoteView Details
Rhodes Jason P
Director
Common Stock
โ€”May 6, 2026Sale428$18.18$7,781.047,962IndirectSee footnoteView Details
Rhodes Jason P
Director
Common Stock
โ€”May 6, 2026Sale17,244$18.18$313,495.921,136,810IndirectSee footnoteView Details
Version: v26.3.33